Prognostic Significance of Selected Tumor Stroma Parameters in Patients with HER2-Positive Breast Cancer Treated with Adjuvant Trastuzumab

Aleksandra Ambicka, Aleksandra Grela-Wojewoda, Joanna Niemiec, Katarzyna Mularz, Agnieszka Harazin-Lechowska, Janusz Ryś, Agnieszka Adamczyk · 2026

Read Prognostic Significance of Selected Tumor Stroma Parameters in Patients with HER2-Positive Breast Cancer Treated with Adjuvant Trastuzumab by Aleksandra Ambicka, Aleksandra Grela-Wojewoda, Joanna Niemiec, Katarzyna Mularz, Agnieszka Harazin-Lechowska, Janusz Ryś, Agnieszka Adamczyk (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13115492.txt.

Description

Simple SummaryBreast cancer is one of the most common cancers, and its outcome can vary greatly depending on the specific characteristics of each tumor. While much attention has been given to features of cancer cells themselves, such as hormone receptors and HER2 status, less is known about the effect of the surrounding tissue—the tumor stroma—on disease progression.

Catalog record

CREATORAleksandra Ambicka, Aleksandra Grela-Wojewoda, Joanna Niemiec, Katarzyna Mularz, Agnieszka Harazin-Lechowska, Janusz Ryś, Agnieszka Adamczyk
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE32 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13115492

Browse the full library · About the Tower of Babel